Agrylin
anagrelide hydrochloride
- Strength
- .5 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
Anagrelide
Listed by ANI Pharmaceuticals, Inc.
- Strength
- .5 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Platelet-reducing Agent
What it contains
- Anagrelide Hydrochloride .5 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Platelet-reducing Agent |
| Approval route | ANDA — approved generic |
| NDC code | 70954-879 |
| FDA application | ANDA076811 |
| RxNorm concept | 597850 |
| Package sizes listed | 1 |
| Marketed since | November 2025 |
Other products containing Anagrelide
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
anagrelide
- Strength
- 1 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
Torrent Pharmaceuticals Limited
Not stocked by us — reference only
Anagrelide
- Strength
- 1 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
Chartwell RX, LLC
Not stocked by us — reference only
Anagrelide
- Strength
- .5 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
Chartwell RX, LLC
Not stocked by us — reference only
anagrelide
- Strength
- .5 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
Torrent Pharmaceuticals Limited
Not stocked by us — reference only
Anagrelide
- Strength
- 1 mg/1
- Form
- Capsule
- Class
- Platelet-reducing Agent
ANI Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.